La catena delle opzioni mostra i dati chiave delle opzioni azionarie di MIND Technology a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per MIND Technology..

MIND Technology (NASDAQ:MIND) Azioni, Catena delle Opzioni

MIND Technology

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The Company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; Europe, Russia & CIS; Middle East & Africa; Asia-Pacific; and Canada & Latin America.

MIND Technology Inc

MIND Technology Inc 9 % Conv Pfd Registered Shs Series -A-

MIND C.T.I. Ltd

MINDS MACHS GROUP LTD by Minds Machs Group Ltd

Mind Cure Health Inc Ordinary Shares

Mind Medicine (MindMed) Inc. - Common Shares

Mind Medicine Inc

Mind Medicine Inc Warrants(07/01/2024)

Mind Medicine Inc Warrants(11/12/2023)

MIND SOLUTIONS INC by Mind Solutions, Inc.

Mind Solutions Inc

Mindful Conservative ETF

Mindset Growth Opportunities I Corp

Mindset Pharma Inc Ordinary Shares

MIND Technology, Inc. ("MIND" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) announced today that its Seamap unit has received an order for a GunLink source controller amounting to approximately $5.1 million.&nbsp; Subsequent to July 31, 2024, the Company has received orders totaling approximately $7.9 million.
Mark Welker, Vice President of MIND and Seamap Managing Director, stated, "We are seeing strong demand for our GunLink source controllers. These most recent orders indicate the continuing demand across our family of source controller products. We expect to deliver a portion of these orders in this fiscal year; however, the majority will be delivered in our next fiscal year.&nbsp; In addition to the orders that we have in hand, we are pursuing a number of significant opportunities that we expect to bring to fruition in the coming weeks and months. We think our continuing backlog and pipeline of business bodes well for the balance of this fiscal year and next year as well."

News

MIND

MIND Technology's Seamap Unit Secures $5.1M GunLink Order, Expands Total to $7.9M

Guidance

MIND Technology Expects To Achieve Revenue Growth, Positive Adjusted EBITDA And Greater Full Year Profitability In FY25

MIND Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) reported quarterly losses of $(0.11) per share which missed the analyst consensus estimate of $0.02 by 650 percent. This is a 93.89 percent increase over losses of $(1.80) per share from the same period last year. The company reported quarterly sales of $10.04 million which missed the analyst consensus estimate of $10.75 million by 6.64 percent. This is a 14.70 percent increase over sales of $8.75 million the same period last year.

Earnings

Earnings Misses

MIND Technology Q2 EPS $(0.11) Misses $0.02 Estimate, Sales $10.04M Miss $10.75M Estimate

MIND Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) is gearing up to announce its quarterly earnings on Wednesday, 2024-09-11. Here's a quick overview of what investors should know before the release.
Analysts are estimating that MIND Technology will report an earnings per share (EPS) of $0.02.
The market awaits MIND Technology's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Past Earnings Performance</h3>
In the previous earnings release, the company missed EPS by $0.30, leading to a 19.54% drop in the share price the following trading session.
Here's a look at MIND Technology's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.3</td>
<td>0.48</td>
<td>-0.20</td>
<td>-1.4</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0</td>
<td>0.39</td>
<td>-1.89</td>
<td>-1.8</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-20.0%</td>
<td>28.999999999999996%</td>
<td>-17.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1725979837_0.png" alt="eps graph" />
<h3>MIND Technology Share Price Analysis</h3>
Shares of MIND Technology were trading at $3.17 as of September 09. Over the last 52-week period, shares are down 47.9%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/MIND/earnings">To track all earnings releases for MIND Technology visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Preview For MIND Technology

MIND Technology, Inc. (&quot;MIND&quot; or the &quot;Company&quot;) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) announced today that the Company&#39;s Board of Directors (the &quot;Board&quot;) has elected not to declare a quarterly cash dividend on its&nbsp;9.00%&nbsp;Series A Cumulative Preferred Stock (&quot;Series A Preferred Stock&quot;) for the&nbsp;second quarter&nbsp;of its fiscal year ending&nbsp;January 31, 2025.
The Company may defer dividend payments on the Series A Preferred Stock, but the dividend is&nbsp;a cumulative dividend that accrues for payment in the future.&nbsp; During a deferral period, the Company is prohibited from paying dividends or distributions on its common stock, or redeeming any of those shares.
If the Company does not pay dividends on its Series A Preferred Stock for six or more quarters, the holders of Series A Preferred Stock will have the right to appoint two directors to the Board.&nbsp; The deferral of the dividend on the Series A Preferred Stock for the&nbsp;second quarter&nbsp;of the fiscal year ending&nbsp;January 31, 2025&nbsp;is the eighth quarterly dividend to be deferred.&nbsp; Accordingly, holders of Series A Preferred Stock have the right to appoint two directors to the Board pursuant to the specific provisions of the Certificate of Designations, Preferences and Rights of MIND Technology, Inc.&nbsp;9.00%&nbsp;Series A Cumulative Preferred Stock, as amended.

Dividends

MIND Technology Defers Series A Preferred Stock Dividend for Eighth Quarter

Shares of Contango Ore, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTGO#NYSE">CTGO</a>) fell sharply during Tuesday's session after the company announced pricing of $15 million <a href="https://www.benzinga.com/quote/CTGO/news">underwritten public offering</a>.
Contango Ore shares dipped 18.4% to $20.34 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Trio Petroleum Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPET#NYSE">TPET</a>) shares jumped 88.2% to $0.4254 after the company completed its first two exploratory wells.</li>
<li>Airship AI Holdings, Inc.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AISP#NASDAQ">AISP</a>) shares climbed 32.5% to $4.1599. Airship AI announced a six-figure sole-source contract award within the Department of Justice for Acropolis Enterprise Video and Data Management Platform.</li>
<li>Blue World Acquisition Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWAQ#NASDAQ">BWAQ</a>) shares gained 30.3% to $9.20 after declining around 4% on Monday.</li>
<li>ShiftPixy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIXY#NASDAQ">PIXY</a>) climbed 29.8% to $1.8950.</li>
<li>Kaixin Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KXIN#NASDAQ">KXIN</a>) rose 26.5% to $0.1769 after gaining around 4% on Monday.</li>
<li>U-BX Technology Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UBXG#NASDAQ">UBXG</a>) jumped 24% to $11.88.</li>
<li>CuriosityStream Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURI#NASDAQ">CURI</a>) rose 24% to $1.24 as the company announced a share repurchase plan.</li>
<li>Nauticus Robotics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KITT#NASDAQ">KITT</a>) gained 21.4% to $0.2802 after surging 49% on Monday.</li>
<li>E-Home Household Service Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EJH#NASDAQ">EJH</a>) rose 19.7% to $0.5270.</li>
<li>Calavo Growers, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVGW#NASDAQ">CVGW</a>) rose 14.1% to $28.50 after the company reported second-quarter financial results.</li>
<li>Moving iMage Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#NASDAQ">MITQ</a>) shares rose 13.1% to $0.6645.</li>
<li>Shoals Technologies Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) rose 10% to $7.49 after the company authorized a share repurchase program of up to $150 million and entered into a $25 million accelerated share repurchase agreement with Jefferies.</li>
<li>Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) jumped 8.8% to $47.74. RBC Capital analyst Brian Abrahams maintained Corbus Pharmaceuticals with an Outperform and raised the price target from $77 to $82.</li>
<li>Lixiang Education Holding Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEH#NASDAQ">LXEH</a>) gained 8.3% to $0.3670.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Big Tree Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSY#NASDAQ">DSY</a>) dipped 37.1% to $6.78.</li>
<li>Target Hospitality Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TH#NASDAQ">TH</a>) shares fell 35.5% to $6.78 after the company announced that it received notice that the U.S. government intends to terminate the existing South Texas Family Residential Center services agreement with its migrant programming partner.</li>
<li>Greenwave Technology Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) dipped 32% to $1.98. Greemwabe Technology Solutions recently announced that its downstream processing system generated record revenues in May, 2024 and reaffirmed its confidence in exceeding its revenue guidance.</li>
<li>Barnes &amp; Noble Education, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNED#NYSE">BNED</a>) declined 29.7% to $0.0941. Barnes &amp; Noble Education announced leadership changes and reverse stock split.</li>
<li>Sify Technologies Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) fell 25% to $0.44. Sify Technologies recently announced the voluntary delisting date of its ADS rights from Nasdaq.</li>
<li>CalAmp Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMP#NASDAQ">CAMP</a>) dipped 23% to $0.5009.</li>
<li>CoreCivic, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXW#NYSE">CXW</a>) shares fell 19.7% to $11.88 after the company announced that it received a notice from the U.S. Immigration and Customs Enforcement that the agency intends to terminate its inter-governmental service agreement for services at the South Texas Family Residential Center.</li>
<li>Vicarious Surgical Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBOT#NYSE">RBOT</a>) declined 19.5% to $0.2878 after the company announced a reverse stock split.</li>
<li>Velo3D, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLD#NYSE">VLD</a>) fell 19% to $0.1151 after the company announced a 1-for-35 reverse stock split.</li>
<li>ProKidney Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROK#NASDAQ">PROK</a>) shares fell 16.1% to $2.5350 after the company announced a proposed $125 million public offering of class A ordinary shares and concurrent registered direct offering.</li>
<li>ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) shares fell 14.9% to $17.48 after gaining 5% on Monday.</li>
<li>MIND Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) dipped 13.6% to $4.8699 following weak quarterly sales.</li>
<li>Rapport Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAPP#NASDAQ">RAPP</a>) fell 13.4% to $22.67.</li>
<li>Montana Technologies Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRJ#NASDAQ">AIRJ</a>) fell 12.8% to $8.80.</li>
<li>Hut 8 Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUT#NASDAQ">HUT</a>) fell 8.6% to $9.00</li>
<li>Hoth Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOTH#NASDAQ">HOTH</a>) shares fell 7.8% to $0.9225. Hoth Therapeutics shares fell around 12% on Monday after the company announced a joint development agreement with Wise Systems International to utilize the BioNeMo AI platform of Nvidia.</li>
<li>Array Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) fell 6.9% to $13.02. Array Technologies announced the departure of Chief Financial Officer.</li>
<li>CleanSpark, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) fell 6.6% to $14.66 amid a pullback in Bitcoin.</li>
<li>Yext, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YEXT#NYSE">YEXT</a>) shares declined 6.3% to $4.7208 after the company reported worse-than-expected first-quarter financial results, issued weak second-quarter guidance and announced it will acquire Hearsay Systems.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/06/39269848/alphabet-to-rally-over-28-here-are-10-top-analyst-forecasts-for-tuesday">Alphabet To Rally Over 28%? Here Are 10 Top Analyst Forecasts For Tuesday</a>

Intraday Update

Markets

Movers

Trading Ideas

AIRJ

AISP

ARRY

BNED

BWAQ

CAMP

CLSK

CRBP

CTGO

CURI

CVGW

GWAV

HOTH

KITT

KXIN

LXEH

MITQ

PIXY

PROK

RAPP

RBOT

SHLS

SIFY

TPET

UBXG

YEXT

Why Contango Ore Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

WIIM

MIND Technology shares are trading lower after the company reported worse-than-expected Q1 sales results.

MIND Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) reported quarterly sales of $9.68 million which missed the analyst consensus estimate of $12.05 million by 19.68 percent. This is a 23.11 percent decrease over sales of $12.59 million the same period last year.

MIND Technology Q1 Sales $9.68M Miss $12.05M Estimate

Shares of H&amp;E Equipment Services, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEES#NASDAQ">HEES</a>) fell sharply during Tuesday's session following <a href="https://www.benzinga.com/quote/HES/earnings">mixed first-quarter results</a>.
H&amp;E Equipment posted GAAP earnings of 71 cents per share, versus market estimates of 77 cents per share. The company's quarterly sales came in at $371.357 million versus expectations of $352.518 million, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
H&amp;E Equipment Services shares dipped 18.2% to $48.45 on Tuesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Akili, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKLI#NASDAQ">AKLI</a>) shares jumped 67.2% to $0.3927 after the company announced Shionogi has canceled and forgiven a $5.0 million long-term debt obligation and agreed to make certain payments for SDT-001.</li>
<li>AGBA Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGBA#NASDAQ">AGBA</a>) gained 57.5% to $3.70 after the company highlighted plans for its previously-announced merger with Triller.</li>
<li>Cyclacel Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) climbed 55.4% to $2.12 after falling over 9% on Monday.</li>
<li>Global Mofy Metaverse Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMM#NASDAQ">GMM</a>) shares gained 50.2% to $1.40 after the company&#8217;s Gauss AI teamed with Heartdub to develop the Gausspeed generative AI platform.</li>
<li>GeneDx Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WGS#NASDAQ">WGS</a>) rose 40.8% to $15.49 after the company reported better-than-expected first-quarter financial results and raised its FY2024 sales guidance.</li>
<li>Eliem Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELYM#NASDAQ">ELYM</a>) gained 39.4% to $7.00.</li>
<li>Swvl Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWVL#NASDAQ">SWVL</a>) surged 29.8% to $13.14 after announcing results for the fiscal year 2023.</li>
<li>Next.e.GO N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGOX#NASDAQ">EGOX</a>) gained 26.4% to $0.0349.</li>
<li>Blend Labs, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) shares climbed 25.8% to $2.83 after the company announced a strategic partnership with Haveli Investments, including a $150 million investment.</li>
<li>Daré Bioscience, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DARE#NASDAQ">DARE</a>) rose 24.2% to $0.3460 after the XOMA acquired an economic interest in the company&#8217;s women&#8217;s health assets. Also, the company announced that the transaction allows it to focus on advancing Phase 3 first-in-category women&#8217;s health product candidates.</li>
<li>LendingTree, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>) gained 24.2% to $46.39 after the company beat first-quarter estimates and issued strong guidance.</li>
<li>MIND Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) rose 24% to $5.85 following quarterly results.</li>
<li>Mullen Automotive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MULN#NASDAQ">MULN</a>) gained 19.8% to $6.85.</li>
<li>Harmonic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLIT#NASDAQ">HLIT</a>) rose 19.2% to $11.19 following a first-quarter revenue beat.</li>
<li>Marin Software Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) rose 18.8% to $3.1002 after the company announced the launch of its AI-powered Anomaly Detector.</li>
<li>ATI Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATI#NYSE">ATI</a>) gained 15.5% to $59.94 following upbeat quarterly results.</li>
<li>Clearwater Paper Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLW#NYSE">CLW</a>) gained 15.2% to $46.88 following better-than-expected earnings.</li>
<li>LSB Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LXU#NYSE">LXU</a>) rose 13.4% to $9.32 following strong quarterly earnings.</li>
<li>SES AI Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) gained 13.3% to $1.53.</li>
<li>E2open Parent Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETWO#NYSE">ETWO</a>) rose 12.5% to $4.7950 following upbeat results.</li>
<li>Sensata Technologies Holding plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ST#NYSE">ST</a>) shares climbed 12.1% to $40.04 as the company reported stronger-than-expected results for its first quarter on Monday. The company said Jeff Cote will retire as CEO and President. Sensata said it sees second-quarter adjusted earnings of 89 cents to 95 cents per share on revenue of $1.025 billion to $1.055 billion.</li>
<li>Addex Therapeutics Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADXN#NASDAQ">ADXN</a>) jumped 10.3% to $8.31. Addex shares dipped 53% on Monday after the company announced the Phase 2 ADX71149 epilepsy study did not achieve statistical significance for the primary endpoint of time for patients to reach baseline seizure count when ADX71149 was added to standard of care.</li>
<li>AgEagle Aerial Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#NASDAQ">UAVS</a>) gained 10.4% to $0.77. AgEagle announced $3.4 million drone sale to French Army.</li>
<li>Tenet Healthcare Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) rose 9.2% to $108.28 after the company reported better-than-expected first quarter earnings and issued strong guidance.</li>
<li>Brinker International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) gained 7.5% to $53.38 after the company reported strong third-quarter financial results and raised FY24 guidance.</li>
<li>Eli Lilly and Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) rose 6.6% to $785.51 after the company raised its FY24 revenue guidance.</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) gained 5.5% to $97.25 following a first-quarter earnings beat.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Lichen China Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) fell 30.6% to $1.4127 after surging 48% on Monday.</li>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) declined 29.7% to $1.25.</li>
<li>Chegg, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) shares fell 26.1% to $5.30 after the company posted first-quarter results and named Nathan Shultz as CEO.</li>
<li>NRx Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRXP#NASDAQ">NRXP</a>) dipped 25% to $2.6592 after the company announced findings from its Phase 2b/3 trial of NRX-101 vs. Lurasidone.</li>
<li>Bakkt Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKKT#NYSE">BKKT</a>) fell 23.5% to $7.62. Bakkt Holdings is expected to release its first quarter 2024 earnings on Tuesday, May 14.</li>
<li>Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) shares declined 22.6% to $27.50 after the company reported mixed first-quarter financial results.</li>
<li>Vince Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) were down 21.4% to $1.6536 after the company posted fourth-quarter results.</li>
<li>NewGenIvf Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) fell 20.1% to $1.63.</li>
<li>Top Wealth Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWG#NASDAQ">TWG</a>) dipped 18% to $1.14.</li>
<li>MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) declined 16.4% to $1,081.53 after the company reported worse-than-expected financial results for the first quarter.</li>
<li>Safe &amp; Green Holdings Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) fell 16% to $0.1185 after declining 4% on Monday.</li>
<li>ArcBest Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) declined 15.8% to $108.96 after the company reported worse-than-expected first quarter adjusted EPS results.</li>
<li>CECO Environmental Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CECO#NASDAQ">CECO</a>) fell 15% to $21.59 after the company reported worse-than-expected first-quarter sales results.</li>
<li>GE HealthCare Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>) declined 13.2% to $77.22 following a first-quarter earnings miss.</li>
<li>Coursera, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COUR#NYSE">COUR</a>) shares declined 13.1% to $10.34 after the company reported mixed first-quarter financial results and issued FY24 revenue guidance below estimates.</li>
<li>Complete Solaria, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSLR#NASDAQ">CSLR</a>) fell 12.5% to $0.6393. Complete Solaria shares jumped 92% on Monday after the company named T.J. Rodgers as CEO.</li>
<li>Transocean Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) fell 11% to $5.18 after the company reported worse-than-expected quarterly sales results.</li>
<li>Warner Bros. Discovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) declined 9.3% to $7.39 on reports NBCUniversal is preparing an offer that could take NBA rights from TNT.</li>
<li>F5, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) fell 7.6% to $168.36. F5 reported upbeat earnings for its second quarter, but issued weak forecast for the third quarter.</li>
<li>Molson Coors Beverage Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAP#NYSE">TAP</a>) declined 7.5% to $58.80 following quarterly results.</li>
<li>The Macerich Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAC#NYSE">MAC</a>) fell 7.4% to $14.82 following quarterly earnings.</li>
<li>Yum China Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUMC#NYSE">YUMC</a>) shares declined 7.3% to $37.13. Yum China posted upbeat earnings for its first quarter, while sales missed expectations.</li>
<li>Rambus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBS#NASDAQ">RMBS</a>) shares declined 7.3% to $56.10 following first-quarter results.</li>
</ul>
Now Read This: <a href="http://Domino's Pizza To Rally Over 10%? Here Are 10 Top Analyst Forecasts For Tuesday">Domino&#8217;s Pizza To Rally Over 10%? Here Are 10 Top Analyst Forecasts For Tuesday</a>

ADXN

AGBA

AKLI

ARCB

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLND

CECO

CETX

CHGG

COUR

CSLR

CYCC

DARE

EGOX

ELYM

ETWO

FFIV

GEHC

HEES

HLIT

LICN

MRIN

MSTR

MULN

NIVF

NRXP

RMBS

SGBX

SWVL

TREE

UAVS

VNCE

YUMC

Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

MIND Technology shares are trading higher. The company reported Q4 financial results.

MIND Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) reported quarterly earnings of $0.39 per share which missed the analyst consensus estimate of $0.48 by 18.75 percent. This is a 343.75 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $13.378 million which missed the analyst consensus estimate of $13.500 million by 0.90 percent. This is a 50.82 percent increase over sales of $8.870 million the same period last year.

MIND Technology Q4 2024 GAAP EPS $0.39 Misses $0.48 Estimate, Sales $13.378M Miss $13.500M Estimate

Contracts

MIND Technology Announces Seamap Unit Awarded Order By ATLAS MARIDAN

Shares of Compugen Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgen#NASDAQ">CGEN</a>) shares rose sharply during Tuesday&rsquo;s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program.
Compugen shares jumped 204.1% to $2.22 on Tuesday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) gained 73% to $0.4853. Intelligent Bio Solutions received National Association of Testing Authorities accreditation for its Intelligent Fingerprinting Drug Screening Solution.</li>
<li>Panbela Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbla#NASDAQ">PBLA</a>) shares surged 64% to $1.6601. Panbela Therapeutics shares jumped 120% on Monday after US WorldMeds received FDA approval of eflornithine.</li>
<li>Jin Medical International Ltd.(NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zjyl#NASDAQ">ZJYL</a>) climbed 49.2% to $151.96 after jumping around 264% on Monday.</li>
<li>ProSomnus, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/osa#NASDAQ">OSA</a>) gained 27.6% to $0.8017. ProSomnus announced data published by Cureus Journal of Medical Science showed successful treatment of obstructive sleep apnea with prosomnus precision oral appliance devices.</li>
<li>Infobird Co., Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ifbd#NASDAQ">IFBD</a>) shares gained 27.4% to $1.7266 after the company inked a new business cooperation in software development of information technology system.</li>
<li>MIND Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mind#NASDAQ">MIND</a>) rose 23.1% to $5.86.</li>
<li>Yoshiharu Global Co. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/yosh#NASDAQ">YOSH</a>) rose 21.1% to $6.20.</li>
<li>Optex Systems Holdings, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/opxs#NASDAQ">OPXS</a>) gained 18.2% to $4.86.</li>
<li>Sunnova Energy International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nova#NASDAQ">NOVA</a>) jumped 16.3% to $15.32. Piper Sandler upgraded Sunnova Energy Intl from Neutral to Overweight and raised the price target from $13 to $26.</li>
<li>Cipher Mining Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cifr#NASDAQ">CIFR</a>) rose 16% to $3.6450.</li>
<li>LogicMark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lgmk#NASDAQ">LGMK</a>) gained 15.7% to $1.0650.</li>
<li>Checkpoint Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ckpt#NASDAQ">CKPT</a>) climbed 13.8% to $2.0825. HC Wainwright &amp; Co. reiterated Checkpoint Therapeutics with a Buy and maintained a $34 price target.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) gained 13.6% to $49.64 after the company announced it has expanded its services to self-checkout at Walmart stores.</li>
<li>PureCycle Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pct#NASDAQ">PCT</a>) gained 13.2% to $3.17. Roth MKM downgraded PureCycle Technologies from Buy to Neutral and lowered the price target from $6 to $3.</li>
<li>bioAffinity Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biaf#NASDAQ">BIAF</a>) rose 12.2% to $1.57.</li>
<li>Sunrun Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/run#NASDAQ">RUN</a>) gained 9.4% to $19.72 after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $15 to $31.</li>
<li>Chewy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chwy#NYSE">CHWY</a>) rose 7.1% to $23.22. Jefferies initiated coverage on Chewy with a Buy rating and announced a price target of $27.</li>
<li>Marathon Digital Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) gained 6% to $21.09. Marathon Digital entered into a definitive agreement Tuesday to acquire two <a href="https://www.benzinga.com/money/bitcoin-mining-software/">Bitcoin mining</a> sites for $178.6 million.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>BYND Cannasoft Enterprises Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcan#NASDAQ">BCAN</a>) fell 49.3% to $0.3501 after the company reported pricing of $1.5 million registered direct offering.</li>
<li>Motus GI Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mots#NASDAQ">MOTS</a>) shares fell 45.6% to $1.17 after the company priced its $5 million public offering.</li>
<li>CureVac N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cvac#NASDAQ">CVAC</a>) declined 35.7% to $3.7384. CureVac announced decision of German Federal Patent Court in broad patent litigation with BioNTech SE.</li>
<li>ETAO International Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/etao#NASDAQ">ETAO</a>) fell 34.7% to $0.3001. ETAO International received a staff determination letter, on Dec. 13, 2023, from the Listing Qualifications Department of The Nasdaq Stock Market LLC.</li>
<li>Shengfeng Development Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfwl#NASDAQ">SFWL</a>) declined 32.4% to $3.24.</li>
<li>Banzai International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bnzi#NASDAQ">BNZI</a>) fell 26.5% to $4.5006.</li>
<li>Biodexa Pharmaceuticals Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bdrx#NASDAQ">BDRX</a>) declined 20.2% to $2.4150 after the company disclosed the pricing of a public offering.</li>
<li>AEye, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lidr#NASDAQ">LIDR</a>) fell 18.8% to $0.0820. Representatives of Continental informed AEye that Continental intends to discontinue the parties&#39; joint lidar development program, including any further development of the HRL131 lidar product line.</li>
<li>Invivyd, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ivvd#NASDAQ">IVVD</a>) fell 16.4% to $3.00. Morgan Stanley upgraded Invivyd from Underweight to Equal-Weight and raised the price target from $1 to $4.</li>
<li>Biomerica, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bmra#NASDAQ">BMRA</a>) shares fell 16.3% to $1.3798. Biomerica shares gained around 67% on Monday after the company received FDA 510(k) clearance for its Hp Detect ELISA test product.</li>
<li>BIO-key International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bkyi#NASDAQ">BKYI</a>) declined 16.3% to $0.1461. Following stockholder approval, BIO-Key announced a 1-for-18 reverse stock split to regain compliance with Nasdaq minimum bid price requirement.</li>
<li>bluebird bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/blue#NASDAQ">BLUE</a>) shares fell 14.2% to $2.6180 after the company announced a proposed public offering of $150 million of common stock.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zvsa#NASDAQ">ZVSA</a>) fell 14% to $0.92 after surging 38% on Monday.</li>
<li>Diversified Energy Co PLC (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dec#NYSE">DEC</a>) declined 12% to $15.77.</li>
<li>Alaunos Therapeutics, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcrt#NASDAQ">TCRT</a>) fell 10.6% to $0.0513 after jumping 26% on Monday.</li>
<li>uniQure N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qure#NASDAQ">QURE</a>) fell 9.8% to $7.20 after announcing updated interim data on Phase I/II clinical trials of AMT-130 gene therapy for the treatment of Huntington&#39;s disease.</li>
<li>iCoreConnect Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/icct#NASDAQ">ICCT</a>) fell 8.3% to $2.1193 after jumping over 35% on Monday.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/earnings/23/12/36296621/how-to-earn-500-a-month-from-general-mills-stock-ahead-of-quarterly-earnings-report"> How To Earn $500 A Month From General Mills Stock Ahead of Quarterly Earnings Report</a>

Penny Stocks

Small Cap

AFRM

BCAN

BDRX

BIAF

BKYI

BLUE

BMRA

BNZI

CGEN

CHWY

CIFR

CKPT

CVAC

ETAO

ICCT

IFBD

Intelligent Bio Solutions Inc. - Common Stock

INBS

IVVD

LGMK

LIDR

MARA

MOTS

NOVA

OPXS

PBLA

QURE

SFWL

TCRT

YOSH

ZJYL

ZVSA

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

MIND Technology shares are trading higher after the company announced that its Seamap unit received a $10.2 million order for multiple GunLink source controllers.

This order is pursuant to the previously disclosed framework supply agreement with a major international seismic contractor.

MIND Technology Earlier Announced That Its Seamap Unit Received An Order For Multiple GunLink Source Controllers Totaling ~$10.2M

Shares of Amtech Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asys#NASDAQ">ASYS</a>) shares fell sharply during Thursday&rsquo;s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.
Amtech reported quarterly sales of $27.70 million, missing the analyst consensus estimate of $34.50 million. The company anticipated first-quarter revenue to be between $21 million and $24 million, versus the $34.15 million estimate.
Benchmark analyst Mark Miller downgraded Amtech Systems from Buy to Hold.
Amtech Systems shares fell 30.6% to $4.16 on Thursday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Freight Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/frgt#NASDAQ">FRGT</a>) shares jumped 322% to $1.14 after the company announced Amazon Mexico renewed its selection of Fr8App for its logistical solutions.</li>
<li>SRIVARU Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/svmh#NASDAQ">SVMH</a>) rose 74.8% to $0.7000.</li>
<li>XBP Europe Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xbp#NASDAQ">XBP</a>) shares gained 49% to $8.46 after declining around 20% on Wednesday.</li>
<li>TPI Composites, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tpic#NASDAQ">TPIC</a>) rose 46% to $3.1350 as the company announced refinancing transaction with Oaktree, significantly strengthening company&rsquo;s liquidity position and enhancing financial flexibility.</li>
<li>Nxu, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxu#NASDAQ">NXU</a>) rose 43.6% to $0.0280 after the company signed a letter of intent outlining investment in Lynx Motors.</li>
<li>Canterbury Park Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cphc#NASDAQ">CPHC</a>) rose 31% to $18.70.</li>
<li>View, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/view#NASDAQ">VIEW</a>) gained 29% to $5.14.</li>
<li>Hanryu Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hryu#NASDAQ">HRYU</a>) gained 27.1% to $1.3850 after jumping 28% on Wednesday.</li>
<li>Esperion Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/espr#NASDAQ">ESPR</a>) shares climbed 23.2% to $1.8603. Esperion said that the FDA updated LDL-C lowering indication for NEXLETOL (bempedoic acid) tablet and NEXLIZET (bempedoic acid and ezetimibe) tablet.</li>
<li>Redfin Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdfn#NASDAQ">RDFN</a>) gained 21.8% to $10.26.</li>
<li>Codexis, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdxs#NASDAQ">CDXS</a>) shares surged 20.5% to $2.5184. Codexis announced achievement of gram-scale synthesis with its ECO Synthesis platform.</li>
<li>Vista Gold Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vgz#NYSE">VGZ</a>) gained 20% to $0.4010. Vista Gold announced a $20 million royalty with Wheaton Precious Metals Corp. on Mt Todd.</li>
<li>Altice USA, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/atus#NYSE">ATUS</a>) rose 18.8% to $2.4950.</li>
<li>Sunnova Energy International Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nova#NYSE">NOVA</a>) gained 18.3% to $14.09.</li>
<li>Wayfair Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/w#NYSE">W</a>) rose 17.3% to $66.75.</li>
<li>Sunrun Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/run#NASDAQ">RUN</a>) gained 16.7% to $17.42.</li>
<li>Blend Labs, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/blnd#NYSE">BLND</a>) surged 16.7% to $2.1950. Blend Labs Head of Finance and Admin. Amir Jafari acquired a total of 12,610 shares at an average price of $1.22.</li>
<li>Moderna, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) rose 15.8% to $91.14. Moderna and Merck &amp; Co announced follow-up data from the Phase 2b randomized KEYNOTE-942/mRNA-4157-P201 study of mRNA-4157 (V940), an investigational individualized neoantigen therapy (INT), in combination with Keytruda in patients with resected high-risk melanoma (stage III/IV) following complete resection.</li>
<li>VCI Global Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vcig#NASDAQ">VCIG</a>) gained 15.4% to $2.62 after its financial technology arm, Accuventures Sdn Bhd, agreed to acquire the Malaysian digital platform EVOLET.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pacb#NASDAQ">PACB</a>) surged 14.2% to $10.12. Stephens &amp; Co. initiated coverage on Pacific Biosciences with an Overweight rating and announced a price target of $11.</li>
<li>Alector, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alec#NASDAQ">ALEC</a>) rose 14.8% to $7.92. Stifel upgraded Alector from Hold to Buy and raised the price target from $8 to $15.</li>
<li>Opendoor Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/open#NASDAQ">OPEN</a>) gained 14.4% to $4.71.</li>
<li>Enphase Energy, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/enph#NASDAQ">ENPH</a>) rose 13.6% to $122.22.</li>
<li>Plug Power Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plug#NASDAQ">PLUG</a>) gained 12.7% to $4.8550.</li>
<li>Alcoa Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aa#NYSE">AA</a>) gained 11% to $28.84. Alcoa received approval for continued mining in Western Australia.</li>
<li>RH (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rh#NYSE">RH</a>) gained 7.3% to $304.60.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Reneo Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rphm#NASDAQ">RPHM</a>) shares dipped 87.3% to $0.9861. Reneo Pharmaceuticals said its pivotal STRIDE study of mavodelpar in adult patients with primary mitochondrial myopathies did not meet its primary efficacy or secondary efficacy endpoint.</li>
<li>Mynd.ai, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mynd#NYSE">MYND</a>) fell 53.1% to $2.71.</li>
<li>Cepton, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cptn#NASDAQ">CPTN</a>) fell 24.2% to $3.01 after the company posted downbeat third-quarter sales and issued weak FY23 revenue forecast. Craig-Hallum downgraded Cepton from Buy to Hold.</li>
<li>Apellis Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apls#NASDAQ">APLS</a>) declined 20.7% to $49.81 after the company announced it was informed of a negative trend vote on the marketing authorization application for pegcetacoplan.</li>
<li>NextCure, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtc#NASDAQ">NXTC</a>) fell 20.7% to $1.15 after the company issued year-end clinical pipeline updates.</li>
<li>MIND Technology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mind#NASDAQ">MIND</a>) dipped 19.4% to $4.7414 following weak quarterly results.</li>
<li>Aditxt, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adtx#NASDAQ">ADTX</a>) fell 16.4% to $5.26.</li>
<li>Ocular Therapeutix, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocul#NASDAQ">OCUL</a>) shares fell 15.1% to $3.3450. Ocular Therapeutix priced its public offering of 30.8 million common share stock at $3.25 per share for gross proceeds of $100.1 million.</li>
<li>NextPlay Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtp#NASDAQ">NXTP</a>) shares fell 11.4% to $1.3905 after jumping 68% on Wednesday.</li>
<li>Regis Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rgs#NYSE">RGS</a>) shares fell 9.9% to $8.39. NYSE will begin delisting proceedings against Regis Corp.</li>
<li>ABM Industries Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/abm#NYSE">ABM</a>) dipped 9.5% to $47.33. ABM recently reported better-than-expected fourth-quarter financial results and issued guidance.</li>
<li>Intensity Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ints#NASDAQ">INTS</a>) shares fell 9.4% to $8.94 after jumping 22% on Wednesday. Intensity Therapeutics recently named Joseph Talamo as CFO.</li>
<li>AerSale Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asle#NASDAQ">ASLE</a>) shares fell 8% to $13.60. AerSale priced its secondary offering of 4 million common shares.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) fell 7.6% to $19.95.</li>
<li>Adobe Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adbe#NASDAQ">ADBE</a>) fell 6.2% to $585.55. Adobe posted upbeat earnings for its fourth quarter, but issued weak sales forecast for full-year 2024.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/12/36231379/wait-for-a-pullback-youre-late-to-the-party-jim-cramer-says-about-this-tech-stock"> &#39;Wait For A Pullback &mdash; You&#39;re Late To The Party&#39;: Jim Cramer Says About This Tech Stock</a>

ADBE

ADTX

ALEC

APLS

ASLE

ASYS

ATUS

CDXS

CPHC

CPTN

ENPH

ESPR

FRGT

HRYU

INTS

MRNA

MYND

NXTC

NXTP

OCUL

OPEN

PACB

PLUG

RDFN

RILY

RPHM

SVMH

TPIC

VCIG

VIEW

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

MIND Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) reported its Q3 earnings results on Wednesday, December 13, 2023 at 04:15 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
MIND Technology missed estimated earnings by 35.0%, reporting an EPS of $-0.27 versus an estimate of $-0.2.
Revenue was up $90 thousand from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.4 which was followed by a 1.29% increase in the share price the next day.

To track all earnings releases for MIND Technology <a href="https://www.benzinga.com/quote/MIND/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: MIND Technology Q3 Earnings

MIND Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.20) by 35 percent. This is a 91.29 percent increase over losses of $(3.10) per share from the same period last year. The company reported quarterly sales of $4.97 million which missed the analyst consensus estimate of $10.50 million by 52.63 percent. This is a 1.84 percent increase over sales of $4.88 million the same period last year.

MIND Technology Q3 EPS $(0.27) Misses $(0.20) Estimate, Sales $4.97M Miss $10.50M Estimate

<h3>Companies Reporting Before The Bell</h3>
&bull; VersaBank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VBNK#NASDAQ">VBNK</a>) is expected to report earnings for its fourth quarter.
&bull; Cognyte Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGNT#NASDAQ">CGNT</a>) is expected to report earnings for its third quarter.
&bull; Photronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAB#NASDAQ">PLAB</a>) is likely to report earnings for its fourth quarter.
&bull; ABM Indus (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) is estimated to report quarterly earnings at $0.92 per share on revenue of $2.03 billion.
&bull; REV Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REVG#NYSE">REVG</a>) is estimated to report quarterly earnings at $0.34 per share on revenue of $666.13 million.
&bull; WisdomTree International LargeCap Dividend Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOL#NYSE">DOL</a>) is likely to report quarterly earnings at $0.86 per share on revenue of $1.47 billion.
<h3>Companies Reporting After The Bell</h3>
&bull; Streamline Health Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STRM#NASDAQ">STRM</a>) is expected to report earnings for its third quarter.
&bull; Amtech Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASYS#NASDAQ">ASYS</a>) is estimated to report quarterly earnings at $0.05 per share on revenue of $34.50 million.
&bull; Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) is likely to report quarterly earnings at $4.14 per share on revenue of $5.03 billion.
&bull; Nordson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NDSN#NASDAQ">NDSN</a>) is projected to report quarterly earnings at $2.39 per share on revenue of $706.76 million.
&bull; MIND Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) is expected to report quarterly loss at $0.20 per share on revenue of $10.50 million.
&bull; Ocean Power Techs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/OPTT#AMEX">OPTT</a>) is projected to report earnings for its second quarter.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

CGNT

WisdomTree Trust International LargeCap Dividend

NDSN

OPTT

PLAB

REVG

STRM

VBNK

Earnings Scheduled For December 13, 2023

MIND Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIND#NASDAQ">MIND</a>) is set to give its latest quarterly earnings report on Wednesday, 2023-12-13. Here's what investors need to know before the announcement.
Analysts estimate that MIND Technology will report an earnings per share (EPS) of $-0.20. 
MIND Technology bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company missed EPS by $0.40, which was followed by a 1.29% increase in the share price the next day.
Here's a look at MIND Technology's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-1.4</td>
<td>-0.7</td>
<td>-0.3</td>
<td>-1.8</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-1.8</td>
<td>-0.9</td>
<td>-0.3</td>
<td>-3.1</td>
</tr>
<tr>
<td>Price Change %</td>
<td>1.29%</td>
<td>-19.61%</td>
<td>11.32%</td>
<td>-0.76%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1702389637_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of MIND Technology were trading at $5.24 as of December 08. Over the last 52-week period, shares are up 17.36%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/MIND/earnings">To track all earnings releases for MIND Technology visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For MIND Technology

MIND Technology (MIND) has shared an update. The Company recently announced the postponement of its special meeting for preferred stockholders, emp...

MIND Technology Delays Stockholders' Special Meeting

MIND Technology: Preferred Stockholders Should Vote For Proposed Common Share Conversion

MIND Technology: Preferred Conversion Has Me Intrigued

Comments

MIND Technology

MIND Technology (MIND) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO